Goldman Sachs’s Aethlon Medical AEMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-4
Closed -$3.92K – 5886
2022
Q4
$3.92K Buy
+4
New +$7.29K ﹤0.01% 5828
2019
Q3
– Hold
0
– -$4K – 5142
2019
Q2
– Hold
0
– – – 5091

Other funds holding AEMD

Goldman Sachs's AEMD Position: Q1 2023 in Review

Goldman Sachs sold out of Aethlon Medical (AEMD) in Q1 2023, closing a stake of 4 shares — an estimated $3.92K sold.

Goldman Sachs first reported a position in AEMD in Q4 2022 and held it in 1 quarter. The position peaked at $3.92K in Q4 2022. 20 funds tracked by Wall St. Rank hold AEMD as of Q1 2023.

  • Goldman Sachs reported no remaining Aethlon Medical position as of Q1 2023 after selling out during the quarter.
  • Goldman Sachs sold 4 Aethlon Medical shares in Q1 2023, an estimated $3.92K.
  • Goldman Sachs first reported a position in Aethlon Medical in Q4 2022 and held it in 1 quarter.
  • Goldman Sachs's Aethlon Medical position peaked at $3.92K in Q4 2022.
  • 20 funds tracked by Wall St. Rank held Aethlon Medical as of Q1 2023.

Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.